Citigroup
MRKR icon

Citigroup’s Marker Therapeutics MRKR Stock Holding History

Citigroup’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$571 Buy
+534
New +$677 ﹤0.01% 5581
2026
Q1 		– Sell
-6
Closed -$9 – 6222
2025
Q4 		$9 Sell
6
-9,270
-100% -$10.5K ﹤0.01% 5820
2025
Q3 		$8.28K Buy
+9,276
New +$11.5K ﹤0.01% 5080
2022
Q2 		– Sell
-70
Closed – – 6499
2022
Q1 		$0 Buy
+70
New +$400 ﹤0.01% 6508
2021
Q3 		– Sell
-7
Closed – – 6104
2021
Q2 		$0 Sell
7
-235
-97% -$6.19K ﹤0.01% 6300
2021
Q1 		$5K Sell
242
-310
-56% -$7.09K ﹤0.01% 5895
2020
Q4 		$8K Buy
552
+410
+289% +$6.36K ﹤0.01% 7012
2020
Q3 		$2K Sell
142
-237
-63% -$4.32K ﹤0.01% 7307
2020
Q2 		$8K Sell
379
-389
-51% -$8.51K ﹤0.01% 7136
2020
Q1 		$15K Buy
768
+225
+41% +$5.73K ﹤0.01% 6859
2019
Q4 		$16K Buy
543
+409
+305% +$14.9K ﹤0.01% 7023
2019
Q3 		$6K Sell
134
-625
-82% -$36.9K ﹤0.01% 7280
2019
Q2 		$60K Sell
759
-3,895
-84% -$231K ﹤0.01% 6307
2019
Q1 		$307K Buy
+4,654
New +$272K ﹤0.01% 4683

Other funds holding MRKR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Ashton Thomas Private Wealth
Ashton Thomas Private Wealth Scottsdale, Arizona $4.98B AUM 21.09% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Hilltop National Bank
Hilltop National Bank Casper, Wyoming $465M AUM 31.11% 1-Year Est. Return
Jacobi Capital Management
Jacobi Capital Management Pittston, Pennsylvania $2.11B AUM 19.6% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Citigroup's MRKR Position: Q3 2026 in Review

Citigroup opened a new position in Marker Therapeutics (MRKR) in Q3 2026: 534 shares worth $571. The stake represents ﹤0.01% of the portfolio and ranks #5581 among its holdings. This is a return to the name: Citigroup previously reported a position in MRKR as recently as Q4 2025.

Citigroup first reported a position in MRKR in Q1 2019 and has held it in 14 quarters since. The position peaked at $307K in Q1 2019. 11 funds tracked by Wall St. Rank hold MRKR as of Q3 2026.

  • Citigroup held 534 shares of Marker Therapeutics worth $571 as of Q3 2026.
  • Marker Therapeutics was a new Citigroup position in Q3 2026.
  • Marker Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5581 holding.
  • Citigroup first reported a position in Marker Therapeutics in Q1 2019 and has held it in 14 quarters since.
  • Citigroup's Marker Therapeutics position peaked at $307K in Q1 2019.
  • 11 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.